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Myelin is a component of the nervous system that is disrupted in multiple
sclerosis, resulting in neuro-axonal degeneration. The longitudinal effect of chronic
cuprizone-induced demyelination was investigated in the cerebral gray and white
matter of treated mice and the spontaneous remyelination upon treatment interruption.
Multimodal Magnetic Resonance Imaging and a Cryoprobe were used at 11.7T to
measure signal intensity ratios, T2 values and diffusion metrics. The results showed
significant and reversible modifications in white matter and gray matter regions such as in
the rostral and caudal corpus callosum, the external capsule, the cerebellar peduncles,
the caudate putamen, the thalamus, and the somatosensory cortex of treated mice.
T2 and radial diffusivity metrics appeared to be more sensitive than fractional anisotropy,
axial diffusivity or mean diffusivity to detect those cuprizone-induced changes. In the gray
matter, only signal and T2 metrics and not diffusion metrics were sensitive to detect any
changes. Immunohistochemical qualitative assessments in the same regions confirmed
demyelination and remyelination processes. These multimodal data will provide better
understanding of the dynamics of cuprizone-induced de- and remyelination in white and
gray matter structures, and will be the basis to test therapies in experimental models.
Keywords: multiple sclerosis, demyelination, remyelination, cuprizone, T2, diffusion
INTRODUCTION
The myelin sheath is an essential component of the vertebrate nervous system enabling an
accelerated conduction of nerve impulses together with reduced energy consumption. In the
human central nervous system, several debilitating diseases are secondary to myelin damage, the
most frequent being multiple sclerosis (MS), where recurrent episodes of demyelination result in
neuro-axonal degeneration. Promotingmyelin repair, an endogenous process that was shown to fail
as disease progresses, is a crucial therapeutic challenge in MS. Not only should it allow restoration
Abbreviations: CPZ, cuprizone; TX, treatment; WM, white matter; GM, gray matter; CC, corpus callosum; cCC, caudal
corpus callosum; rCC, rostral corpus callosum; CP, cerebellar peduncle; EC, external capsule; CPu, caudate putamen; TH,
thalamus; Sr, signal ratio.
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of normal conduction and functional recovery, but it may
also prevent axonal and neuronal degeneration. Such a
neuroprotective role of myelin could be particularly important
in the cortical gray matter (GM) where myelin sheaths, despite
being less abundant, could play a crucial role in neuronal
survival (Kang et al., 2013). Interestingly the existence of GM
demyelinating cortical lesions in the brains of MS subjects, which
are now known to be an important hallmark of MS (Kidd et al.,
1999; Kutzelnigg et al., 2005; Nelson et al., 2008; Geurts et al.,
2011; Mike et al., 2011; Staugaitis et al., 2012), has recently been
demonstrated. Such cortical demyelination is thought to appear
during the first stages of the disease, but subsequently becomes
increasingly pronounced during the later phases. This process
could be a contributing factor in disability amongMS patients. In
addition, efficient remyelinating abilities have been observed in
such lesions, with an even higher efficiency than in white matter
(WM) lesions (Chang et al., 2012).
The cuprizone (CPZ) mouse model is frequently used to
recapitulate demyelination that occurs in MS. Cuprizone is a
copper chelator (biscyclohexanone oxaldihydrazone) that causes
cell death of the oligodendrocytes, leading to demyelination
(see review by Torkildsen et al., 2008). This neurotoxin has
been used in mice since 1966 and is administered in food
(Carlton, 1966). Mice fed with CPZ were initially described as
presenting WM demyelination mainly in the corpus callosum
(CC) and in the cerebellar peduncles (CP) (Suzuki and Kikkawa,
1969; Matsushima and Morell, 2001). Recent investigations have
pointed that CPZ treated mice were also characterized by an
extended GM demyelination occurring in the cerebellar cortex
(Skripuletz et al., 2010), in the deep GM, and in the cerebral
cortex (Skripuletz et al., 2008, 2011; Xiao et al., 2008). A key
feature of the CPZ model is that following withdrawal of the
toxin, remyelination takes place spontaneously with a high
level of efficacy both in WM and GM areas, especially when
a short-duration CPZ exposure paradigm is applied, i.e., 5–6-
week treatment (TX) (Skripuletz et al., 2011). When the TX is
prolonged for 12 weeks, the remyelination process is delayed and
only partly efficient (Armstrong et al., 2006; Skripuletz et al.,
2008; Lindner et al., 2009). Overall the CPZ model enables
the investigation of the mechanisms of remyelination both in the
WMand in the GM, either in optimal or deficient conditions. The
development of repair therapies requires methods to monitor
myelin dynamics in living individuals. Magnetic Resonance
Imaging (MRI) is widely used to study brain disorders.
Conventional structural imaging using T2 contrast easily enables
the detection of macroscopic WM lesions, however it is not
specific of a particular biological abnormality, and generally fails
to identify cortical demyelination due to weak spatial resolution
and sparse cortical network of fibers in the cortex resulting in
poor contrast for myelin. Diffusion-weighted MRI is based on
the diffusion of water molecules, which can be restricted by
membranes, and can thereby provide differential measurements
of myelin and axonal integrity (Song et al., 2002; Bodini et al.,
2015). Several MRI studies attempted to visualize demyelination
and remyelination in the WM of mice treated with CPZ using
different MRI techniques such as T2-weighted imaging, which
showed enhanced signal in demyelinated regions (Yu et al., 2004;
Merkler et al., 2005; Thiessen et al., 2013), diffusion-weighted
imaging (Song et al., 2005; Sun et al., 2006; Wu et al., 2008;
Boretius et al., 2012; Zhang et al., 2012) showing increased
radial diffusivity (RD) and decreased fractional anisotropy (FA)
in demyelinated regions, or magnetization transfer imaging
(Zaaraoui et al., 2008; Turati et al., 2015) showing decreased
magnetization transfer ratios after demyelination and recovery
after remyelination. More recently, WM tract integrity metrics
derived from diffusion kurtosis imaging have been shown to be
more specific to assess the WM microstructural changes in the
CPZ model (Jelescu et al., 2016).
However, most of these studies have focused on the CC, and
none has explored the dynamics of GMpathology.We used ultra-
high-field MRI and a CryoProbeTM in order to provide increased
signal-to-noise ratio (SNR) and resolution to investigate both
GM and WM alterations over 7 brain regions during TX and
recovery in the chronic CPZ mouse model.
MATERIALS AND METHODS
Animal Model
All animal experiments were performed in accordance with the
European Council Directive (88/609/EEC).
We used C57Bl/6J PLP-GFP L42 transgenic mice, where the
fluorescent GFP was spontaneously expressed in myelin. Six 8-
week old female mice were fed with 0.2% CPZ and imaged before
TX and 12 weeks after TX. The animals were then fed normal
chow during 12 additional weeks and weighed on a daily basis.
They were imaged at 6 weeks (n = 5) and 12 weeks (n = 4)
without TX to monitor recovery. One mouse was sacrificed at
12 weeks of TX and one mouse at 12 weeks of recovery for
immunohistochemical assessment.
Throughout all imaging sessions, the animals were
anesthetized with 1–1.5% isoflurane (Abbott Animal Health)
mixed with oxygen (1:5 O2:air) delivered through a nose cone at a
flow rate of 1 L/min. Physiological parameters were recorded via
a monitoring system (S.A. Instruments Inc.). The temperature of
the animals was maintained at 37◦C through a circulating heated
water system, and measured with a rectal probe. The respiration
of the animals was monitored using a pressure pad positioned
under their abdomen.
Data Acquisition
All images were acquired with an 11.7-T system (Bruker Biospec
117/16 USR horizontal bore, 750 mT/m gradients, Paravision
5.1, Ettlingen, Germany) and a helium-cooled 1H quadrature
transmit-receive surface CryoProbeTM for mouse head (Bruker,
Ettlingen, Germany). The receiver gain was manually adjusted
to optimize the gain over the upper 3/4 of the brain. High-
resolution anatomical T2-weighted (T2w) images were acquired
with a 2D rapid acquisition with relaxation enhanced sequence;
repetition time (TR) = 6000 ms; echo time (TE) = 40ms;
Matrix = 256 × 256; field-of-view (FOV) = 15.36 × 15.36mm2;
resolution = 60 × 60µm2; slice thickness = 220µm; number of
excitations = 1; acquisition time = 17min. Parametric T2 maps
were obtained from a multi-slice multi-echo sequence with TR
= 5500ms; TE = 15–120ms/5-ms increments; Matrix = 128 ×
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128; FOV = 12.8 × 12.8mm2 (resolution = 100 × 100µm2);
slice thickness= 200µm; number of excitations= 2; acquisition
time = 15min. Three-dimensional diffusion echo-planar images
were acquired with TR = 500 ms; TE = 20ms; Matrix = 160 ×
96× 32; FOV= 24× 14.4× 9.6 mm3 (resolution= 150× 150×
300µm3); 46 directions; b = 1000 s/mm2; δ = 4ms; 1 = 10ms;
acquisition time= 41min.
Data Analysis
The T2w images were coregistered using the Linear Image
Registration Tool from the Oxford Center for Functional MRI
of the Brain (Jenkinson and Smith, 2001; Jenkinson et al.,
2002). Signal ratios (Sr) were calculated from the coregistered
images between the signal in manually-drawn regions of interest
(ROIs) in the GM or WM and the signal from the cerebrospinal
fluid as done by Yu et al. (2004) and Chandran et al. (2012),
using the Image Processing and Analysis in Java software
(http://imagej.nih.gov). T2 values were calculated from a pixel-
wise regression fit function from the multi-echo sequence using
the PV5.1 image sequence analysis tool package. Diffusion
parametric maps were also generated from the Paravision 5.1
package. Diffusion metrics such as FA, AD (as a marker of
axonal damage), RD (as a marker of myelin damage) and mean
diffusivity (MD) were measured.
Anatomical landmarks were used to position the ROIs at
the same place in all mice (Figure 1). The ROIs included the
FIGURE 1 | T2-weighted coronal images of the dynamics of demyelination/remyelination over the course of the pre-TX (A,D,G,J), 12w TX (B,E,H,K) and
12w no TX phases (C,F,I,L). Hyperintensities were detected after 12 weeks (12w) of TX in CPu, EC, and rCC (B); in CP (E); in TH and cCC (H); and in S1 (K). After
12 weeks without TX (C,F,I,L), the signal intensities decreased back. Manually-drawn regions of interest are shown in the middle panel in white.
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rostral and caudal CC (rCC and cCC), the external capsule
(EC), the primary somatosensory cortex (S1), the cerebellar
peduncles (CP), the dorsal caudate putamen (CPu) and the
ventral posteromedial and posterolateral thalamic nuclei (TH).
Measurements for a given ROI were averaged from the left and
the right hemispheres over 3 adjacent slices.
To compare the experimental groups at different time
points, the statistical analysis was performed using the Matlab
mutlcompare function for pairwise multiple comparison (Matlab
7.11.0 R2010b, Statistics Toolbox). The results were considered
statistically significant when the comparison intervals were
disjoint. The p values were corrected for multiple comparisons
and considered significant for p < 0.05. Either the comparison
intervals or the p-values are provided. Each timepoint for each
ROI was compared to the other 3 timepoints. All error bars
correspond to the standard error of the mean.
Full recovery was established when the two following
conditions were fulfilled: (i) a significant difference was
detected between the 12-week TX timepoint and either
the 6-week or 12-week recovery timepoints and (ii) no
significant difference was found between the pre-TX and the
6-week or 12-week recovery timepoints. Partial recovery was
established when either or both of the following conditions
were fulfilled: (i) a significantly low difference was detected
between the 12-week TX timepoint and either the 6-week or
12-week recovery timepoint and (ii) no significant difference
was found between the pre-TX and the 6-week or 12-
week recovery timepoints; or when a significant difference
was detected between both (i) the 12-week TX timepoint
and the 6-week or 12-week recovery timepoints and (ii)
between the pre-TX and the 6-week or 12-week recovery
timepoints.
Immunohistochemical Assessment
Two mice were sacrificed (one at 12 weeks of TX and one
at 12 weeks with no TX), and perfused intracardially with
4% paraformaldehyde in phosphate buffer saline. The extracted
brains were then post-fixed overnight at 4◦C in the same fixative,
cryoprotected for several hours at 4◦C in phosphate buffer saline
containing 30% sucrose, and frozen in melting isopentane. The
brains were then sliced in 20µm thick sections with a Microm
cryostat for myelin assessment with PLP/GFP (proteolipid
protein/green fluorescent protein). Microscopic scans of whole
sections (pixel size 0.25µm2) were acquired with a Nanozoomer
2.0-RSslide scanner (Hamamatsu Photonics, Hamamatsu Japan).
Co-localization of brain regions with MR images was performed
using anatomical landmarks from similar slices.
RESULTS
Signal Ratios
Signal enhancement was clearly visible from the T2w images at
12 weeks of TX in rCC, CPu, EC, CP, cCC, TH, and S1 (Figure 1,
middle column) and some recovery was also visible at 12 weeks
with no TX (Figure 1, right column) compared to the pre-TX
baseline signal (Figure 1, left column).
Measurements of Sr after 12 weeks of TX showed significant
enhancement in the superior CP (p< 0.006), TH (p< 0.005), S1
(interval [−15.6; −3.1]), rCC (p < 0.03), cCC (p < 0.004) and
EC (p < 0.04) (Figure 2). After recovery (no TX) Sr fully came
back to their initial values in TH (p< 0.005 at 12 weeks) and rCC
(p < 0.03 at 6 weeks), only partially in S1 (interval [−0.6;13.8]; p
< 0.2 at 12 weeks). No significant recovery of Sr was found in CP,
CPu, cCC, or EC. However, no significant difference was found
FIGURE 2 | Significant increase of Sr after 12 weeks (12w) of TX in most structures. Sr values came back to initial values after 6 weeks (6w) or 12 weeks
without TX in TH and rCC, partially in S1 and not in CP, Cpu, cCC, or EC. *p < 0.05; **p < 0.01.
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between pre-TX and no TX at 6 weeks in EC, which indicated
partial recovery in this structure.
T2 Values
T2 values (Figure 3) significantly increased in all GM and WM
structures after 12 weeks of TX compared to pre-TX (CPu: p <
0.002; TH: p< 0.02; S1: p< 0.03; rCC: p< 0.01; cCC: p< 0.004;
EC: p< 0.004). They then fully returned to initial values without
TX in CPu (p< 0.04 at 12 weeks), in TH (p< 0.03 at 6 weeks), in
rCC (p< 0.02 at 6 weeks) and in EC (p< 0.002 at 12 weeks). Only
partial recovery was found in cCC as a significant difference was
found both between the 12-week TX timepoint and the 12-week
recovery timepoint, and between the 12-week TX timepoint and
the pre-TX timepoint (p < 0.004). The T2 values measurements
did not detect any recovery in S1 unlike Sr measurements.
Diffusion
After 12 weeks of TX, FA values decreased in all WM structures
compared to preTX, and then increased back 6 weeks after
recovery (Table 1). However, these changes were not significant
due to large variability in the data (Figure 4A).
RD values significantly increased 12 weeks after TX in cCC
(p < 0.03), and non-significantly in rCC (p < 0.1) and in EC
(p < 0.2) compared to preTX (Table 1). During the recovery
phase, RD values fully returned to their initial values at 6 weeks
in rCC (interval [1.1;13.8]), at 12 weeks in cCC (p < 0.03) and
non-significantly in EC at 6 weeks (interval [−0.2;12.2]) (Table 1;
Figure 4B). These RD results suggest clear demyelination during
the TX phase in WM structures then remyelination during the
recovery phase.
AD measurements showed no significant changes in rCC and
EC (Figure 4C). In cCC, non-significant decrease of AD was
measured at 12 weeks of TX, and at 6 weeks and 12 weeks without
TX compared to before TX (Table 1), suggesting a progressive
effect of the TX on AD values in cCC.
MD mildly increased in rCC and EC at 12 weeks of TX
compared to before TX but not in cCC (Table 1, Figure 4D).
After 6 weeks of recovery, MD values returned to initial values
in rCC and in EC, however those results were not significant due
to large variability in the data (Table 1).
In GM regions, no changes in diffusion metrics were detected.
Immunohistochemical Assessment
Immunohistochemical evaluation of coronal brain sections at 12
weeks of TX confirmed demyelination in CC, EC, CPu, TH, and
in S1 cortex identified as decreased GFP fluorescence. After 12
weeks of recovery a clear but less bright fluorescence reappeared
in the same regions reflecting myelin regeneration. However, at
this stage we found heterogeneity in the fluorescence intensity,
which was more extended and more intense in CC and EC
and showed intermediate intensity in GM regions, especially in
the cortex. ROIs analyzed on MRI were analyzed in parallel by
immunohistochemistry (Figure 5), showing that MRI changes
with time were associated with myelin regeneration in the same
regions.
DISCUSSION
Main Results
We used the chronic CPZ demyelinating model and we showed
that ultra-high-field MRI with a CryoProbeTM was sensitive
FIGURE 3 | T2 values. Significant increase of T2 in all structures after 12 weeks (12w) of TX. Full or partial recovery after 6 weeks (6w) or 12 weeks without TX in all
structures, except in S1. *p < 0.05; **p < 0.01.
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TABLE 1 | Diffusion metric values in white matter.
FA RD AD MD
PRE-TX
cCC 0.61 ± 0.07 0.00054±0.00003 0.0015± 0.0001 0.00087± 0.00004
rCC 0.51 ± 0.08 0.00059±0.00004 0.0014± 0.0001 0.00085± 0.00007
EC 0.31 ± 0.02 0.00058±0.00003 0.0009± 0.00002 0.00071± 0.00003
12-WEEK TX
cCC 0.50 ± 0.06 0.00063 ± 0.00005* 0.0013± 0.0001 0.00087± 0.00006
rCC 0.44 ± 0.09 0.00070±0.00009 0.0013± 0.0002 0.00088± 0.00005
EC 0.26 ± 0.04 0.00064±0.00003 0.0009± 0.00006 0.00074± 0.00004
6-WEEK NO TX
cCC 0.54 ± 0.05 0.00059±0.00005 0.0012± 0.0001 0.00083± 0.00005
rCC 0.53 ± 0.08 0.00056 ± 0.00008# 0.0014± 0.0001 0.00082± 0.00006
EC 0.32 ± 0.03 0.00059±0.00002 0.0009± 0.00007 0.00070± 0.00003
12-WEEK NO TX
cCC 0.55 ± 0.02 0.00055 ± 0.00005# 0.0013± 0.00007 0.00081± 0.00002
rCC 0.54 ± 0.04 0.00060±0.00011 0.0014± 0.00006 0.00083± 0.00003
EC 0.31 ± 0.04 0.00062±0.000008 0.0009± 0.00003 0.00072± 0.000005
The values represent mean ± standard deviation; *statistically different from pre-TX (p < 0.03); #statistically different from 12-week TX (p < 0.03). RD, AD, and MD values are in mm2/s.
Significant values are in bold.
for the detection and the quantification of demyelination and
remyelination processes. Following the 12-week CPZ TX, T2w
sequences, either by quantifying Sr or T2 values, could capture
demyelination inWMareas such as in CC and in EC, but was also
shown to be sensitive enough for measuring demyelination in the
deep GM and in the cortex. Diffusion-weighted metrics were less
sensitive to demyelination in the GM and could only quantify
myelin loss and recovery (RD changes) in the main WM tracts
(in accordance with already published data on the CPZ model
treated for 6 weeks, Song et al., 2005; Zhang et al., 2012). When
the neurotoxic agent was removed, a clear improvement of Sr and
T2 value paralleling myelin regeneration on immunohistological
samples was found both in theWM and in the deep GM, whereas
in S1, only a mild trend to normalization of Sr was detected. In
some regions, Sr and T2 values measurements showed varying
levels of sensitivity in detecting demyelination (e.g., in CPu) or
remyelination (e.g., in cCC or EC).
We also observed mild tremor and rigidity in mice under TX,
which disappeared during recovery.
Model Considerations
In this chronic 12-week TX paradigm we showed that a
significant level ofmyelin regeneration could indeed occur within
the 12 weeks that follow the interruption of TX, contrary to
the previous idea that longer CPZ exposure was associated with
failing remyelination (Armstrong et al., 2006). However, under
this condition the remyelination was overall suboptimal and
delayed compared to the classical 6-week TX paradigm where a
complete remyelination is expected to occur within 4–6 weeks.
This confers a major interest for the paradigm we used here, as it
reproduces more closely the in vivo condition observed in human
diseases such as MS, where remyelination is quite slow and
incomplete. This system could provide an opportunity to better
investigate candidate promyelinating drugs in this experimental
model not only for their potential to accelerate the process of
remyelination, but also for their ability to enhance the amount
of myelin regeneration in unfavorable conditions.
Our results also indicate that the sensitivity of ultra-high-
field MRI could be of interest to investigate myelin dynamics
in GM regions, as a significant recovery was observed in deep
GM regions together with a trend toward normalization of Sr
in S1. Demyelinating lesions in the MS cortex were identified
as strongly associated with physical and cognitive disability in
MS (Calabrese et al., 2009), suggesting that their potential to
remyelinate could be a crucial prognosis factor. On the other
hand, pathological investigations have well attested that even in
late stages of the disease, these lesions may retain a significant
ability to spontaneously regenerate myelin (Chang et al., 2012).
Therefore, the identification of putative promyelinating therapies
positively acting on cortical remyelination has recently emerged
as one of the key objective to reach in the regenerative
approach for MS. The imaging methodology we used in the
CPZ model may enable selection of candidate drugs depending
on their impact on cortical repair. The smaller amount of
myelin contained in the cortex compared to WM drastically
decreases the sensitivity of the T2w sequence to myelin content
changes, explaining why the recovery did not reach statistical
significance using T2 measurements in this limited sample
of animals. In addition, the ad libitum intake of CPZ could
account for the large variability between mice, although the
animals’ weights were fairly similar. Further studies should
include larger samples (however 5–8 mice were also used in
most other similar studies, Song et al., 2005; Zhang et al.,
2012) and may allow the detection of significant changes,
especially when cortical remyelination is pharmacologically
enhanced.
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FIGURE 4 | Diffusion measurements. Mild and reversible decrease of FA after 12 weeks (12w) of TX (A), although not significant. Reversible increase of RD in cCC,
rCC, and EC (B). No significant changes in AD (C). Mild increase of MD at 12 weeks of TX and decrease at 6 weeks (6w) without TX in rCC and EC (D). RD, AD, and
MD values are in mm2/s. *p < 0.05.
Imaging Considerations
The use of both a very high magnetic field (11.7T) and a
Cryoprobe in this study enabled very high resolution with high
SNR in the T2w sequence with a voxel volume of 0.8 × 10
−3
mm3 acquired in only 17min, compared to voxel volumes used
in similar studies with lower fields and conventional probes: from
1.6× 10−3 mm3 at 2.35T (scan time not provided) (Merkler et al.,
2005), to 3 × 10−3 mm3 in 20min at 9.4T (Zhang et al., 2012),
and to 7 × 10−3 mm3 in 10min (Thiessen et al., 2013) and 10
× 10−3 mm3 (scan time not provided) (Chandran et al., 2012) at
7T. Our voxel volume was 2 to more than 10 times smaller than
in other studies with comparable scan times, which conferred to
our T2w protocol an increased sensitivity to detect signal changes
in numerous WM and GM brain regions.
Although a disadvantage of T2w sequences could have been
their non-specificity to a particular type of brain lesion, these
sequences are highly sensitive, especially at very high resolutions
(60µm). In the model used, the requirement for sensitivity
primed over specificity as the underlying pathology at the time
that it was investigated and mainly consisted of myelin dynamic
changes, with no edema or blood-brain barrier leakage, and only
a minor inflammatory component as the microglial reaction
predominates between the 3rd and the 5th week of TX and
subsequently decreases in this model (Skripuletz et al., 2011).
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FIGURE 5 | Colocalization of demyelinated and remyelinated regions between MRI (A–K) and PLP/GFP immunohistochemical sections (A′–K′) before
TX, 12 weeks (12w) after TX, and 12 weeks after TX removal. The dotted circle represents CPu and the arrow points to rCC.
Other sequences such as diffusion or magnetization transfer
imaging were described as more specific for myelin compared to
T2w sequences, however they suffer from lower spatial resolution,
less reproducibility and worse SNR. While these sequences are
of great interest for the quantitative investigation of the myelin
compartment, they may be less sensitive to mild or moderate
myelin dynamic changes, as attested by the negative results
described in this study for diffusion parameters in the GM.
Along the same line of results, magnetization transfer imaging
showed some changes following the CPZ TX in the deep GM,
but failed to detect any change in the cortex (Fjær et al.,
2013).
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Methodological Considerations
Although T2 values are known to shorten with aging in normal
mouse brains from about−0.05 to−0.1ms/100 days asmeasured
by Falangola et al. at 7T (Falangola et al., 2007), no significant
changes in C57Bl6 WT mice were expected throughout our
study as shown by Sun et al. MRM 2006 who also used 8-
week old C57Bl6 mice for the first timepoint with a similar
experimental protocol (longitudinal follow-up from 12-week of
TX to 12-week of recovery, 4.7T). We calculated the estimated
mean T2 values from those rates of changes for the control
group over all timepoints. We found that the maximum percent
change in T2 was −0.66% by the last timepoint (168 days
later). From our data, we were able to detect significant T2
changes in the order of 3.2–30% between timepoints, which
was 5–50 times larger than the estimated T2 changes of the
control group over time. We can therefore consider that the
significance of our T2 results would have remained unchanged
even with an additional age-matched control group at each
timepoint. Interestingly, a recent study (Jelescu et al., 2016)
showed T2 reductions in the order of 8% over an 18-week
period in the CC of similar control mice. These results suggest
that T2 shortens more in regions highly dense in myelinated
WM than regions poorly dense in WM as shown in Falangola’s
study.
Our analysis method was based on manually drawn ROIs
and did not allow for systematic evaluation of the entire brain,
which explains why the cerebellum and the cortex were not
thoroughly examined so that more lesions could potentially
be detected (e.g., in the cerebellar WM). However, automatic
or semi-automatic measurement methods based on normalized
ROIs on a template have limitations for very small regions such
as CC or EC: errors in measurements can arise from misaligned
ROIs and subsequent manual adjustments are necessary and
time-consuming.
Perspectives
Overall this work emphasizes that ultra-high field MRI is
sensitive enough to quantify dynamic demyelination and
remyelination in the chronic CPZ model both in the WM and in
the GM. This opens the perspective to investigate promyelinating
compounds in vivo for their ability to promote repair in both
regions, a step that will be crucial for the selection of molecules
that should be further developed in early clinical trials in MS.
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